|
|
|
|
|
|
|
Next-Gen Sequencing For Adventitious Agent Detection In Cell Banks
|
|
|
The use of Next Generation Sequencing (NGS) in the biosafety testing space has grown dramatically over the past decade with the advent of advanced instrumentation. Explore a NGS adventitious agent testing (AAT) method for cell line characterization, representative results from a HEK293 master cell bank, and more.
|
|
|
|
|
|
|
Cell banks are the foundation of biologics development, and ensuring their quality and consistency is critical for long-term success. Explore a comprehensive suite of services for the manufacture, characterization, and storage of cell banks, as well as the advantages of working with an experienced partner.
|
|
|
|
|
Optimizing production across master and working cell bank (MCB and WCB) manufacturing requires more than just technical expertise—it demands a partner who understands flexibility, compliance, and scalability. Discover a partner that can help you optimize production.
|
|
|
|
|
|
|
For decades, the genetic stability testing package for biopharmaceutical cell banks has remained relatively unchanged. Examine the first streamlined, single-test replacement of traditional methods that leverages the power of whole genome sequencing and expert bioinformatics to deliver a faster, all-in-one solution for a comprehensive testing package.
|
|
|
|
|
BioReliance® cell banking professionals are experts at Cell Bank production for the biopharma industry. Our cGMP production facilities and extensive technical and regulatory expertise provide the support you need for efficient product development to achieve regulatory approval.
|
|
|
